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Summary
We have found an allelic deletion of the haptoglobin
(Hp) gene from an individual with anhaptoglobinemia.
The Hp gene cluster consists of coding regions of the a
chain and b chain of the haptoglobin gene (Hp) and of
the a chain and b chain of the haptoglobin-related gene
(Hpr), in tandem from the 5′ side. Southern blot and
PCR analyses have indicated that the individual with
anhaptoglobinemia was homozygous for the gene de-
letion and that the gene deletion was included at least
from the promoter region of Hp to Hpr a but not to
Hpr b (Hpdel). In addition, we found seven individuals
with hypohaptoglobinemia in three families, and the
genotypes of six of the seven individuals were found to
be Hp2/Hpdel. The phenotypes and genotypes in one of
these three families showed the father to be hypohap-
toglobinemic (Hp2) and Hp2/Hpdel, the mother to be
Hp2-1 and Hp1/Hp2, one of the two children to be hy-
pohaptoglobinemic (Hp2) and Hp2/Hpdel, and the other
child to be Hp1 and Hp1/Hpdel, showing an anomalous
inheritance of Hp phenotypes in the child with Hp1.
The Hp2/Hpdel individuals had an extremely low level of
Hp (  mg/ml; ), com-mean SD 0.049 0.043 n  6
pared with the level ( mg/ml) obtained from1.64 1.07
52 healthy volunteers having phenotype Hp2, whereas
the serum Hp level of an individual with Hp1/Hpdel was
0.50 mg/ml, which was approximately half the level of
Hp in control sera from the Hp1 phenotype (1.26
mg/ml; ), showing a gene-dosage effect. The0.33 n  9
other allele (Hp2) of individuals with Hp2/Hpdel was
found to have, in all exons, no mutation, by DNA se-
quencing. On the basis of the present study, the mech-
anism of anhaptoglobinemia and the mechanism of
anomalous inheritance of Hp phenotypes were well ex-
plained. However, the mechanism of hypohaptoglobi-
nemia remains unknown.
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Introduction
Haptoglobin (Hp), synthesized in the liver, is a hemo-
globin-binding polymorphic plasma protein and is re-
markable for being the first example in which both a
polymorphism of human plasma proteins and a partial
gene duplication have been substantiated by starch-gel
electrophoresis, by amino acid analysis, and by DNA
sequence analysis (Smithies and Walker 1955; Black and
Dixon 1968; Maeda et al. 1984). In human populations,
there are three common genetic Hp phenotypes—Hp1,
Hp2, and Hp2-1—which are determined by a pair of
codominant alleles— Hp1 and Hp2. The Hp protein is
composed of two pairs of an a chain and a b chain, and
the polymorphism of the protein reflects inherited var-
iations in the Hp a-chain polypeptides (Bowman and
Kurosky 1982). The a chain of the Hp2 protein is com-
posed of 142 amino acid residues and is a product of a
partial gene duplication of the Hp1 a chain, which has
83 residues. An inert allele, Hp0, at the Hp locus has
been postulated by studies on the anomalous inheritance
of Hp phenotypes, and the homozygosity of Hp0 has
also been suggested as a cause for so-called anhaptoglo-
binemia (Harris et al. 1958; Matsunaga et al. 1970).
Maeda et al. (1984) demonstrated that the Hp2 pro-
tein bears a duplication of 59 a-chain amino acid resi-
dues corresponding to intragenic duplication of 1.7 kb
occurring at precise intronic sites of Hp1. In addition,
an extra Hp gene, which shares a high degree of nucle-
otide-sequence homology with Hp1, has been isolated
(Maeda et al. 1984; Bensi et al. 1985; Maeda 1985).
This gene has been designated as the “haptoglobin-re-
lated gene” (“Hpr”). Hp and Hpr are located within the
30-kb region in chromosome 16q22.3 (Maeda 1985),
suggesting thatHpr has evolved by gene duplication and
subsequent divergence.
Although certain pathological states, such as severe
hemolysis and liver dysfunction, are known to lead to
secondary anhaptoglobinemia (Rougemont et al. 1980),
some previous reports have claimed that the hypo- or
anhaptoglobinemia (Hp0 phenotype) observed in trop-
ical countries has a genetic origin (Allison et al. 1958;
Giblett and Steinberg 1960). However, it should be
pointed out that, to date, a satisfactory complete genetic
model has not yet been reported for the Hp0 phenotype.
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Since no detectable change in the Hp gene clusters (in-
cluding promoter region) of Hp0 individuals has been
reported in previous studies (Hill et al. 1986; Maeda
1991), Maeda (1991) have speculated that the null ex-
pression of Hp is related to the trans-acting factors nec-
essary for Hp expression, rather than to cis-acting pro-
moter sequences.
In the present study, we found (1) an individual with
the true anhaptoglobinemia phenotype and (2) that the
homozygosity of a deletion in the Hp gene cluster (Hpdel)
was responsible for the anhaptoglobinemia. The anom-
alous inheritance of Hp phenotypes was well explained
by the presence of allele Hpdel, since, for a long time,
hypohaptoglobinemia has been referred to simply as
“anhaptoglobinemia.”
Material and Methods
Determination of Hp Phenotype and Quantification of
Serum Hp Level
Phenotypes were determined by mixing 20 ml serum
with 10 ml hemolysate (∼3% hemoglobin concentra-
tion), followed by electrophoresis in a 5% polyacryl-
amide gel (Linke 1984). The gel was soaked, for 15 min,
in 40% acetic acid solution containing 0.4% leucoma-
lachite green and then was stained with 3% hydrogen
peroxide. Individuals with serum Hp below the limit of
detection in this method were classified as an- or hy-
pohaptoglobinemic (Hp0 phenotype). The serum Hp
level was then measured by the enzyme-linked immu-
nosorbent–assay (ELISA) method, by use of polyclonal
anti-human Hp and alkaline phosphatase–conjugated
anti-human IgG (EY Laboratories) and with purified Hp
(Sigma) as the standard protein. An individual in whom
ELISA showed complete absence of serum Hp was clas-
sified as anhaptoglobinemic, and individuals in whom
ELISA showed a low but detectable level of serum Hp
were classified as hypohaptoglobinemic. Since anhap-
toglobinemia reported in previous studies may have in-
cluded either or both anhaptoglobinemia and hypohap-
toglobinemia, we have classified such phenotype as Hp0.
Southern Blot Analysis
The genotypes of Hp were determined as described
by Maeda et al. (1984). Genomic DNA was isolated
from peripheral leukocytes from an individual with true
anhaptoglobinemia, from family members, including in-
dividuals with hypohaptoglobinemia, and from healthy
volunteers, by the organic-solvent method (Sambrook et
al. 1989). For Southern blot analysis, genomic DNA
(2–5 mg) was separated in a 0.8% agarose gel after di-
gestion with the appropriate restriction endonuclease,
was transferred onto a nylon membrane, and was hy-
bridized with the digoxigenin-labeled a chain–coding or
b chain–coding region of the Hp cDNA probe (a kind
gift from Universite´ Libre de Bruxelles, Service de Ge´-
ne´tique Applique´e) (Hyland 1988). To normalize the
DNA quantity, the same membrane was rehybridized
with the digoxigenin-labeled 0.5-kb catalytic domain of
human H-type a(1,2)fucosyltransferase gene (FUT1)
probe (Larsen et al. 1990; Koda et al. 1996; Wang et
al. 1997). The digoxigenin-labeled DNA probe was pre-
pared by use of a DIG DNA labeling kit (Boehringer
Mannheim). Hybridization was performed overnight at
68C with 500 mM phosphate buffer (pH 7.2) contain-
ing 7% SDS. The final wash was performed for 40 min
at 68C with 40 mM phosphate buffer (pH 7.2) and 1%
SDS. The intensities of the hybridized bands of x-ray
film were estimated by use of a densitometer (Shimadzu
CS-930).
PCR Amplification of Hp or Hpr, and DNA
Sequencing
Genomic DNA was subjected to PCR amplification
(Saiki et al. 1988). Previously described primers (Maeda
1991) were used for amplification of the promoter region
of Hp (30 cycles of 20 s at 94C, 1 min at 55C, and 1
min at 72C).
To analyze Hp2 of individuals ST and TN (of families
T andN, respectively) with the Hp0 phenotype, all exons
ofHp2 were amplified by PCR and then were sequenced.
Exon 1U (5′-GCAGTGTGAAAA TCC TCCAAGATA
A-3′; 683–707 bp) and exon 1L (5′-AAT TTA GCC CAT
TTG CCC GTT TCT T-3′; 1,135–1,159 bp) primers or
exon 5U (5′-ATT CTC AGAACCAGAGGCAAAGAC
C-3′; 4,286–4,310 bp) and exon 6L (5′-AGT GCC CTT
CAG GCC CTA ATG AAC A-3′; 5,761–5,785 bp) prim-
ers were used for amplification of exon 1 or exons 5 and
6 (30 cycles of 10 s at 98C, 1 min at 60C, and 1 min
30 s at 72C). To avoid the amplification of Hpr, whole
Hp2 was amplified by use of exon 1U and exon 7L ( 5′-
CTG GAC CAT AAA GGA GCA AAT AAA A-3′;
7,473–7,497 bp) primers and a LA PCR kit (Takara)
(30 cycles of 10 s at 98C and 10 min at 68C). Nested
or seminested PCRs were then performed by use of exon
2U ( 5′-TAG CTT TCC ACT CCT CCT TGT CTT C-
3′; 2,515–2,539 bp) and exon 4L (5′-CAG TGC CCT
TCA GGC CCC AAT GAA C-3′; 4,047–4,071 bp) prim-
ers, for amplification of exons 2–4, or by exon 7U (5′-
AGA TGG AAA GGC TCT TGC ACA TTT C-3′;
6,445–6,469 bp) and exon 7L primers, for amplification
of exon 7, by use of 10,000-fold–diluted first PCR prod-
uct as a template (30 cycles of 10 s at 98C, 1 min at
60C, and 1 min 30 s at 72C). For amplification of
exons 2–4 of Hpr, PCR was performed by use of Hpr
exon 2U (5′-CAG CTT TCC GTT CCT CCT TGT TTT
C-3′; 14,226–14,250 bp) and exon 4L (see above;
15,780–15,840 bp) (30 cycles of 10 s at 98C, 1 min at
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Figure 1 Southern blot analysis of genomic DNAs, using Hp a
(A) or Hp b (B) cDNA probes. Genomic DNAs (2 mg) from an in-
dividual with anhaptoglobinemia (lanes A), an individual with hy-
pohaptoglobinemia (lanes H), and a normal control individual (lanes
N) were digested by BamHI. The sizes (in kb) of hybridized fragments
are indicated.
Figure 2 PCR amplification of promoter region of Hp. PCR
products underwent electrophoresis in a 1.2% agarose gel and were
stained by ethidium bromide. The size of the PCR product is indicated.
StyI-digested lambda DNA (lane l/S) was used as a molecular-size
marker.
60C, and 1 min 30 s at 72C). For coamplification of
exon 7 ofHp and of exon 5 ofHpr, PCR was performed
by use of exon 7U and exon 7L primers. Numbering of
the nucleotide sequence followed the notation of Maeda
(1985). The resulting PCR products were subcloned into
plasmid pGEM by use of a pGEM-T vector system I
(Promega), and then the DNA sequence was determined
by use of an ABI PRISM Dye Terminator Cycle Se-
quencing Ready Reaction Kit and an ABI 373 sequencer
(Applied Biosystems) (Koda et al. 1996, 1997).
Results
An Individual with Complete Anhaptoglobinemia
In the initial stage of this study, we investigated the
Hp phenotypes of 9,711 unrelated individuals and
found, by ELISA analysis, an individual with the com-
plete absence of serum Hp (Yoshioka et al. 1991).
Characterization of the Hp Gene Deletion
We investigated the Hp gene cluster in an individual
with anhaptoglobinemia, using Southern blot analysis
with BamHI-digested genomic DNA. As shown in lane
A of figure 1A, no hybridized signal was detected in an
individual who was supposed to be truly anhaptoglo-
binemic, when theHp a cDNA probe was used, whereas
only a 0.6-kb band corresponding to Hpr—but not a
5.0-kb band corresponding toHp—was identified, when
the Hp b cDNA probe was used (fig. 1B, lane A). This
gene deletion was also identified by a failure in PCR
amplification of Hpr a, whereas Hpr b was amplified in
both normal control and anhaptoglobinemic individuals
(data not shown). In addition, the promoter region of
Hp was also not amplified in an anhaptoglobinemic in-
dividual (fig. 2, lane A). These results suggested that a
homozygous gene deletion of the promoter region ofHp,
Hp a, Hp b, and Hpr a—but not Hpr b (Hpdel)—was
responsible for the anhaptoglobinemia phenotype.
To identify the 3′ end of the gene deletion, Southern
blot analysis was performed after digestion of genomic
DNA from the individual with anhaptoglobinemia, by
AatI and the Hp b cDNA probe, since Hpr b appeared
to be not deleted. As shown in figure 3, a 119.3-kb band,
corresponding to Hp b, and a 4.5-kb band, correspond-
ing to Hpr b, were found in a control individual (lane
N), whereas only an unexpected band of 16.0 kb was
observed in the individual with anhaptoglobinemia (lane
A). Maeda (1985) reported that the endonuclease site
for AatI was present in the 5′ flanking region of Hpr b
(intron 4). Although Hpdel appeared to be digested at a
different site for AatI, compared with Hpr b from the
normal allele (figs. 3 and 4), the size of a BamHI frag-
ment of Hpr b was the same in both the normal and the
Hpdel alleles. These results suggested that the 3′ end of
the gene deletion occurred within the 284-bp stretch be-
tween the AatI site within intron 4 and the BamHI site
in exon 5, of Hpr (fig. 4A). Furthermore, Hpr b was
amplified by PCR in the anhaptoglobinemic individual
(data not shown). Since the 5′ PCR primer was ∼200 bp
downstream from the AatI site, the 3′ end of the gene
deletion was within this region.
Screening and Identification of Families with
Hypohaptoglobinemia
We investigated the Hp phenotypes of 300 under-
graduate students in Kurume University and found three
hypohaptoglobinemic individuals (ST, TN, andHH) (fig.
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Figure 3 Southern blot analysis of genomic DNAs, using Hp b
cDNA probe. Genomic DNAs (2 mg) from an individual with anhap-
toglobinemia (lane A), an individual with hypohaptoglobinemia (lane
H), and a normal control individual (lane N) were digested by AatI.
The band indicated by an asterisk (*) is unexpected. The sizes (in kb)
of the hybridized fragments are indicated.
Figure 4 Restriction-endonuclease maps of Hpr gene (panel A) and of Hp gene cluster (panel B). In panel A, sites for restriction
endonucleases (vertical arrowheads), coding regions of exons 4 and 5 of Hpr (rectangles), and an Alu sequence in intron 4 of Hpr (horizontal
arrow) are indicated . A  AatI; B  BamHI; H  HindIII; S  SacI; and X  XbaI. The expected position of the 3′ end of the gene deletion
in Hpr in Hpdel is located within the 284 bp between the AatI site in intron 4 and the BamHI site in exon 5 of the Hpr gene. In panel B, the
expected gene deletion in the Hp gene cluster is shown (double-headed horizontal arrow). The numbers in the Hp gene cluster denote the exons
of Hp and Hpr. Scale bars are given in the lower-right corners of panels A and B.
5). We then investigated the phenotypes of Hp andmeas-
ured the serum Hp level in all the members of these three
families, after obtaining fully informed consent. In two
families (T and N), other individuals with the hypohap-
toglobinemia phenotype were detected, whereas, in the
third family (H), both the father and the mother had
two normal alleles with the phenotype Hp2-1. The phe-
notypes in families T, N, andHwere as follows: in family
T, the father had the hypohaptoglobinemia phenotype
(Hp2), the mother had Hp2-1, one of the two children
(ST) had hypohaptoglobinemia (Hp2), and the other
child had Hp1; in family N, the father had hypohap-
toglobinemia (Hp2), the mother had Hp2, and the three
children all had hypohaptoglobinemia (Hp2); and, in
family H, both the father and the mother were Hp2-1,
one of the two children (HH) had hypohaptoglobinemia
(Hp2), and the other child had Hp2 (fig. 5). All the other
genetic markers that were investigated, such as multi-
locus DNA polymorphism (with oligonucleotide [CAC]5
used as a probe) (Pena et al. 1991) and the D1S80
(pMCT118) locus (Kasai et al. 1990), demonstrated that
within each family the paternity and maternity matched
(data not shown). Thus, one child with phenotype Hp1,
in family T, showed an anomalous inheritance of the Hp
phenotype.
The Hemizygous Genotype Hp2/Hpdel—but Not Hp1/
Hpdel—as a Possible Cause of Familial
Hypohaptoglobinemia
Since an anomalous inheritance of Hp phenotype was
observed in family T, semiquantitative Southern blot
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Figure 5 Summary of three families with hypohaptoglobinemic individuals. The phenotypes and genotypes of Hp, as well as the plasma
Hp levels, of all family members are indicated. The propositi—ST, TN, and HH—in the three families are indicated.
Figure 6 Semiquantitative Southern blot analysis of genomic
DNAs, using Hp a cDNA, Hp b cDNA, or FUT1 as probe. Genomic
DNAs (5 mg) from individuals of family T (F, the father with hypo-
haptoglobinemia [Hp2]; C1, the elder child with hypohaptoglobinemia
[Hp2]; C2, the other child, with Hp1; and M, the mother, with Hp2-
1) and from a normal control individual (N) with Hp2-1 were digested
by BamHI. Coding regions of the a chains of both Hp and Hpr were
visualized by use of the Hp a cDNA probe, and those of the b chains
of both Hp and Hpr were visualized by use of the Hp b cDNA probe.
The band FUT1was visualized by use of the FUT1 probe. The intensity
of the hybridized bands was determined by use of a densitometer.
analysis was performed to investigate the possibility of
an Hp deletion. Genomic DNA from each individual in
family T and from a normal control individual was di-
gested with restriction enzyme BamHI. After separation
by electrophoresis in a 0.8% agarose gel and blotting
onto a nylon membrane, the membrane was hybridized
with Hp a cDNA probe and then was rehybridized with
Hp b cDNA probe and FUT1 probe, sequentially. As
shown in figure 6, Hp a of the father (F) and of one of
the children (C1) showed a single band indicating Hp2,
the other child (C2) showed a single band demonstrating
Hp1, and the mother (M) and a control individual (N)
showed double bands of Hp1/Hp2. The ratios of Hp a,
Hpr a, or Hp b to FUT1 of the father and two children
were approximately half those of the control individual,
whereas those of the mother were similar to those of the
control individual. However, the ratio ofHpr b to FUT1
in all members of family T was similar to that of the
control individual. The same results were obtained for
family N. These results suggested that a hemizygous gene
deletion was present in the father and two children in
family T and in the father and all three children in family
N. However, the deletion of the Hp gene cluster was not
found in the one child in family H who had hypohap-
toglobinemia (HH). When Southern blot analysis was
performed after digestion with endonuclease SacI of ge-
nomic DNA from each individual in family T, a single
band of Hp a was obtained, irrespective of the Hp phe-
notype, and the ratios of Hp a to FUT1, of the father,
the two children, and the mother, compared with those
in the control individual, were 0.6, 0.6 and 0.4, and 1,
respectively (data not shown), indicating a hemizygous
gene deletion also in the Hp gene cluster of the father
and two children. As shown in figure 3, the two bands
corresponding to Hp b and Hpr b, as well as the 16.0-
kb unexpected band, were found in an individual with
hypohaptoglobinemia (lane H), indicating that this in-
dividual was heterozygous for Hp2 and Hpdel. In addi-
tion, when genomic DNAwas digested by SacI, byXbaI,
and by HindIII, only an unexpected band, at 7.5 kb, 6.5
kb, and 4.4 kb, respectively, was found in the individual
with anhaptoglobinemia, and an unexpected band of
similar size, plus bands corresponding to Hp b and Hpr
b, were detected in individuals with hypohaptoglobi-
nemia, by use of theHp b cDNA probe (data not shown).
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We also obtained three bands from the genomic DNA
of the one child (C2) with Hp1, in family T, and from
that of each individual with hypohaptoglobinemia, ex-
cept for child HH, whose gene deletion was not detected.
In addition, we found no unexpected 4.4-kb HindIII
band by use of Southern blot analysis in 95 healthy
individuals. These findings clearly demonstrated that the
same gene deletion found in the individual with anhap-
toglobinemia was present in all members of families T
and N who had hypohaptoglobinemia and in the one
member of family T who had Hp1. Although we found
the same deletion of Hp in two families, relatedness be-
tween the fathers of families T and N was not
established.
To examine the other allele (i.e., Hp2) of individuals
with hypohaptoglobinemia, we isolated all the exons
and exon/intron junctions of Hp2 from individuals ST
and TN (of families T and N, respectively), using PCR
amplification. We found no mutation in these regions,
using DNA sequence analysis.
The six individuals with Hp2/Hpdel had an extremely
low level of Hp ( mg/ml), compared with0.049 0.043
the level ( mg/ml) obtained from 52 healthy1.64 1.07
volunteers having phenotype Hp2 and genotype Hp2,
whereas the serum Hp level of the child (C2) with Hp1/
Hpdel in family T was 0.50 mg/ml, which was approx-
imately half the level of Hp in the control sera from the
Hp1 phenotype ( mg/ml; ), showing a1.26 0.33 n  9
gene-dosage effect (fig. 5).
Discussion
We have described here an allelic deletion in Hp
(Hpdel), and the homozygous gene deletion has been
shown to be associated with the complete absence of
serum Hp, whereas Hp2/Hpdel—but not Hp1/Hpdel—has
been shown to be associated with hypohaptoglobinemia.
Since the complete absence of the Hp gene and protein
was identified in the individual in this study who had
true anhaptoglobinemia, it seems that the Hp protein is
not essential for human survival. The gene deletion oc-
curred from at least the promoter region of Hp to the
5′ flanking region of Hpr b. The 3′ end of the gene de-
letion was present within a region ∼200 bp downstream
from the AatI site of intron 4 inHpr.However, we could
not determine the position of the 5′ end of the gene
deletion. On the basis of a map of the Hp gene cluster
(Maeda 1985), the size of the gene deletion was calcu-
lated to be 120 kb (fig. 4B).
The anomalous inheritance of Hp phenotypes in fam-
ilies having one or more members with Hp0 has been
known for a long time (Harris et al. 1958; Matsunaga
et al. 1970), and a silent allele, Hp0, has been thought
to be responsible for the Hp0 phenotype and for the
mode of inheritance of Hp in these families. It has been
reported that individuals in previous studies who had
Hp0—and who were probably hypohaptoglobi-
nemic—were always associated with Hp2 phenotype,
and anomalous inheritance has been demonstrated in
individuals with the Hp1 phenotype (Harris et al. 1958;
Matsunaga et al. 1970). We also found a similar fam-
ily—that is, family T—in which both the father (F) and
the elder child (C1) were hypohaptoglobinemic (Hp2)
and in which the other child (C2), who hadHp1, showed
an anomalous inheritance of the Hp phenotype, since
the mother (M) had Hp1 and Hp2. The allelic deletion
of Hp (Hpdel) found in the present study can explain the
anomalous inheritance observed in the second child, C2.
Maeda (1991), however, reported the existence of Hp0
in three African American individuals—one having Hp2
and the other two having Hp1—and in two individuals
with Hp2 who were not African American, with no
change in the Hp gene clusters of any of these five Hp0
individuals, using Southern blotting. Since Hp0 in Af-
rican American individuals is known to be frequently
due to secondary anhaptoglobinemia (Allison et al.
1958; Giblett and Steinberg 1960; Rougemont et al.
1980), further study is required in two African American
individuals with Hp0 associated with Hp1. Azevedo et
al. (1969) reported no matings in 29 fam-Hp1#Hp1
ilies, in northeastern Brazil, having one or more indi-
viduals with Hp0.
The Hp gene cluster is located in chromosome
16q22.3, which is well known to contain inheritable
fragile sites (Shabtai et al. 1983; Sutherland et al. 1984).
The loss of the heterozygosity of Hp has been observed
frequently during carcinoma progression (Tsuda et al.
1990). A crossover event has produced a gene dupli-
cation, resulting in the generation of Hp and Hpr in
tandem (Maeda et al. 1984; Maeda 1985). Moreover,
Hp2 has been generated by a nonhomologous crossover
within different introns of two Hp1 alleles (Black and
Dixon 1968; Maeda et al. 1984; Maeda 1985). Fur-
thermore, Maeda et al. (1986) found polymorphisms for
many tandemly arranged Hpr’s in the Hp gene cluster,
formed by gene duplication by homologous but unequal
crossover in some African American individuals, and
suggested that the tandemly arranged Hpr was linked
to Hp2. In addition, a rare phenotype, Hp Johnson, has
been demonstrated to be a threefold tandem repeat of
the same 1.7-kb DNA segment implicated in Hp2 du-
plication (Oliviero et al. 1985). In the present study, we
have found that the phenotype hypohaptoglobinemia is
associated with Hp2, in the presence ofHpdel. Therefore,
these other findings concerning Hp2, together with our
findings, suggest that the chromosome region containing
the Hp gene cluster is especially prone to genomic DNA
rearrangement (Shabtai et al. 1983; Sutherland et al.
1984).
In the present study, we have detected both the ho-
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mozygous gene deletion of the Hp gene cluster, in the
individual with anhaptoglobinemia, and the heterozy-
gous gene deletion, in individuals with hypohaptoglo-
binemia. Since no detectable change in the Hp gene clus-
ters (including the promoter region) of Hp0 individuals
in previous studies (Hill et al. 1986; Maeda 1991) and
of one hypohaptoglobinemia individual (HH) in the
present study has been identified by use of Southern blot
analysis, the cause of hypohaptoglobinemia is not sim-
ple. However, this is the first report to propose a genetic
model for anhaptoglobinemia and the anomalous in-
heritance of Hp phenotypes, although the precise mech-
anism of hypohaptoglobinemia associated with Hp2/
Hpdel remains unknown.
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